Acute blood transfusion reaction in a tertiary care hospital in Southern Punjab, Pakistan
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20191369Keywords:
Adverse transfusion reaction, Pack red cells, Hemovigilance, Febrile nonhemolytic transfusion reactionAbstract
Background: Blood transfusion is a lifesaving process but carries many risks. Majority of these had been reduced with better diagnostic and management strategies. But the risk of non-infectious adverse transfusion reactions though reduced but cannot be eliminated. Hemovigilance is the system to monitor such reactions.
Methods: The objective of current study was to know the frequency of adverse transfusion reactions and to compare it with local and international data. Retrospective cross-sectional descriptive study was done in Ibn-e- Sina hospital. Adverse transfusion reactions reported to blood bank was analysed according to hospital protocol.
Results: Out of 6050 blood transfusions 23 (0.38%) develop adverse transfusion reactions. Febrile nonhemolytic transfusion reaction was the commonest adverse event and whole blood was the component implicated.
Conclusions: Adverse transfusion reactions are non-infectious complications of blood transfusion which in spite of all efforts cannot be avoided. Frequency of adverse transfusion reactions in our study was 0.38% and Febrile nonhemolytic transfusion reaction was commonest reported reaction type. Hemovigilance system is necessary to monitor, investigate and control such activities.
References
Saeed M, Hussain S, Rasheed F, Ahmad M, Arif M, Rahmani MT. Silent killers: Transfusion transmissible infections-TTI, among asymptomatic population of Pakistan. J Pak Med Assoc. 2017;67(3):369-74.
Zameer M, Shahzad F, Khan FS, Ali H, Saeed U, Farooq M. Transfusion transmissible infections among healthy donors at blood bank from Children’s Hospital and Institute of child health, Lahore. Pak Armed Forces Med J. 2017;67(1):131-6.
Mohammed Y, Bekele A. Seroprevalence of transfusion transmitted infection among blood donors at Jijiga blood bank, Eastern Ethiopia: retrospective 4 years study. BMC Res Notes. 2016;9(1):129.
Ali MS, Qowaider SR, Moftah SA. Seroprevalence rates of transfusion-transmitted infections among blood donors in northeast of Libya. J Sci Humanit. 2014;19:1-7.
Bazie EA, Ali MA, Hamza HB, Magzoub OS, Salih MS, Haroun BE. Sero-prevalence of viral transfusion-transmissible infections among blood donors at Kosti Teaching Hospital, White Nile State/Sudan. Int J Curr Microbiol App Sci. 2015;4(5):1132-8.
Arshad A, Borhany M, Anwar N, Naseer I, Ansari R, Boota S, et al. Prevalence of transfusion transmissible infections in blood donors of Pakistan. BMC Hematology. 2016;16(1):27.
Kalpana RS, Arti RA, Aaditi DR. Seroprevalence of transfusion transmissible infections among blood donors at a tertiary care centre in Maharashtra, India. Int J Contemporary Med Res. 2017;4(9):1865-7.
Chaurasia RK, Puja P, Kumar A, Singh P. Pattern of transfusion transmitted infections in blood donors around Bhopal-a 5 years retrospective study. Ann Int Med. 2016;2(6):12-5.
Niazi SK, Mahmood A, Alam M, Ghani E. Seroprevalence of transfusion transmissible infections in blood donors: A three year experience. Pak Armed Forces Med J. 2016;66(2):190-3.
Zaheer HA, Waheed U. National baseline survey on monitoring and evaluation of blood screening systems in Pakistan. J Blood Disord Transf. 2015;7.
Waheed U, Khan H, Satti HS, Ansari MA, Malik MA, Zaheer HA. Prevalence of transfusion transmitted infections among blood donors of a teaching hospital in Islamabad. Ann Pak Inst Med Sci. 2012;8(4):236-9.
Khoyumthem P, Rachandra K, Goswami S, Lyngdoh LN, Sharma AB, Singh AM. Acute transfusion reactions in a tertiary hospital: A 2-year retrospective study. J Med Society. 2018;32(1):47.
Fatima S, Rafique A, Tehsin F. Frequency of Acute Blood Transfusion Reactions encountered in patients in a Tertiary Care Hospital. Pakistan J Med Health Sci. 2017;11(1):120-2.
Vartak UC, Shewale R, Vartak S, Faizal F, Majethia N. Adverse reactions of blood transfusion: A study in a tertiary care Hospital. International J Sci Study. 2016;4(2):90-4.
Khalid S, Usman M, Khurshid M. Acute transfusion reactions encountered in patients at a tertiary care center. J Pak Med Assoc. 2010;60(10):832.
Cho J, Choi SJ, Kim S, Alghamdi E, Kim HO. Frequency and pattern of non-infectious adverse transfusion reactions at a tertiary care hospital in Korea. Annals Laboratory Med. 2016;36(1):36-41.
Hatayama Y, Matsumoto S, Hamada E, Kojima N, Hara A, Hino N, et al. Analysis of acute transfusion reactions and their occurrence times. Yonago Acta Medica. 2018;61:087-90.
Sidhu M, Meenia R, Yasmeen I, Akhtar N. A study of transfusion related adverse events at a tertiary care centre in North India: an initiative towards hemovigilance. Int J Advances Med. 2017;2(3):206-10.
Lubart E, Segal R, Tryhub N, Sigler E, Leibovitz A. Blood transfusion reactions in elderly patients hospitalized in a multilevel geriatric hospital. J Aging Res. 2014;2014.
Borhany M, Anwar N, Tariq H, Fatima N, Arshad A, Naseer I, et al. Acute blood transfusion reactions in a tertiary care hospital in Pakistan‐an initiative towards haemovigilance. Transfusion Med. 2018.
Chavan SK, Patil G, Rajopadhye P. Adverse blood transfusion reactions at tertiary care hospital. Int J Res Med Sci. 2017;4(6):2402-7.
Sina RTK, Rai P, Dey A. A study of transfusion related adverse events at a tertiary care center in central India: A retrospective evaluation. J Med Sci Health. 2016;2(3):6-12.
Allisabanavar S, Dheemantha P, Jayanthi CR, Narayana RS. A regional hemovigilance study of transfusion-related adverse events at a tertiary care hospital. 2018;8(12):1605-8.
Mazzei CA, Popovsky MA, Kopko PM. Noninfectious complications of blood transfusion. In: Mark K, Brenda J, Christophjer D, Connie M, eds. Technical Manual. 18th ed. Bethesda, MD: American Association of Blood Banks; 2014: 665-96.
Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Pre¬vention Atlanta GA, USA. National Healthcare Safety Network Biovigi¬lance Component Hemovigilance Module Surveillance Protocol c.2.1.3. Available at: http://www.cdc.gov/nhsn /PDFs/Biovigilance/BV-HV-protocol-current.pdf. Accessed on 12 January 2019.
